Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting
Go back to Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting| Harmony Metals, Inc. Common (NASDAQ: HRMY) | Delayed: 33.43 +0.15 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.28 | 52 Week High | $1.35 | |||
| Open | $33.46 | 52 Week Low | $0.10 | |||
| Day High | $33.83 | P/E | N/A | |||
| Day Low | $33.10 | EPS | $0.00 | |||
| Volume | 654,241 | |||||
